MedPlus Subsidiary Faces 3-Day Drug License Suspension in Telangana
Optival Health Solutions, a subsidiary of Medplus Health Services, received a three-day suspension order for its drug license at a store in Kapra Saket, Telangana. The suspension, issued by the Assistant Director of Drugs Control Administration, Quthubullapur, is expected to result in a revenue loss of approximately Rs. 0.22 lacs. Medplus Health Services disclosed this information in compliance with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Medplus Health Services , through its subsidiary Optival Health Solutions Private Limited, has encountered a regulatory setback in Telangana. The company received a three-day suspension order for its drug license at a store located in Kapra Saket, Telangana.
Suspension Details
The Assistant Director of Drugs Control Administration, Quthubullapur, Telangana, issued the suspension order under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The order was received on October 14, 2025.
Financial Impact
Medplus Health Services has disclosed the potential financial implications of this suspension in a regulatory filing. The company estimates a revenue loss of approximately Rs. 0.22 lacs due to this temporary closure.
Regulatory Compliance
In adherence to SEBI regulations, Medplus Health Services promptly informed the stock exchanges about this development. The disclosure was made under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Information
| Aspect | Details |
|---|---|
| Affected Entity | Optival Health Solutions Private Limited |
| Parent Company | Medplus Health Services |
| Nature of Action | Drug License Suspension |
| Duration | 3 days |
| Location | Kapra Saket, Telangana |
| Issuing Authority | Assistant Director, Drugs Control Administration, Quthubullapur, Telangana |
| Legal Basis | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 |
| Estimated Revenue Loss | Rs. 0.22 lacs |
This incident underscores the regulatory challenges faced by pharmaceutical retail chains and the importance of maintaining strict compliance with drug and cosmetics regulations. While the financial impact appears minimal, it serves as a reminder of the ongoing regulatory scrutiny in the pharmaceutical retail sector.
Investors and stakeholders of Medplus Health Services may want to monitor the company's responses to such regulatory actions and any measures implemented to prevent future occurrences.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.68% | +3.11% | +0.58% | -10.63% | -4.54% | -27.49% |
19
